Bradykinin B2 receptor antagonism
搜索文档
Pharvaris (NasdaqGS:PHVS) Earnings Call Presentation
2025-12-03 21:00
RAPIDe-3 Topline Data Disclosure December 3, 2025 ©2025 1 Disclaimer This Presentation contains certain "forward‐looking statements" within the meaning of the federal securities laws that involve substantial risks and uncertainties. All statements contained in this Presentation that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements relating to our future plans, studies and trials, and any statements containing the words "be ...